BMC Medical Co., Ltd. (SHE:301367)
China · Delayed Price · Currency is CNY 44.36
+0.58 (1.32%)
At close: Jul 31, 2026
BMC Medical Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 1,203 | 1,159 | 843.48 | 1,122 | 1,415 | 662.5 |
Revenue Growth | 31.26% | 37.46% | -24.85% | -20.70% | 113.64% | 18.20% |
Gross Profit Gross Profit Growth | 640 | 603.55 | 394.17 | 503.14 | 587.22 | 285 |
Operating Income Operating Income Growth | 214.88 | 223.31 | 96.98 | 264.51 | 398.2 | 150.47 |
Net Income Net Income Growth | 192.15 | 225.66 | 155.38 | 297.34 | 380.3 | 145.68 |
Earnings Per Share EPS Growth | 1.54 | 1.81 | 1.24 | 2.37 | 3.83 | 1.55 |
EPS Growth | 8.66% | 45.97% | -47.59% | -38.11% | 147.04% | -35.96% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Surgical & Medical Equipment Surgical & Medical Equipment Growth | 1,202 | 1,158 | 842.24 | 1,119 | 1,413 | 662.5 |
Unallocated Other Operating Income Unallocated Other Operating Income Growth | - | 1.36 | 1.24 | 3.01 | 2.62 | - |
Total Total Growth | 1,203 | 1,159 | 843.48 | 1,122 | 1,415 | 662.5 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 2,528 | 2,586 | 2,810 | 2,523 | 2,516 | 408.94 |
Total Debt Total Debt Growth | 49.32 | 84.01 | 402.94 | 26.75 | 21.06 | 4.11 |
Net Cash (Debt) Net Cash Growth | 2,479 | 2,502 | 2,407 | 2,496 | 2,495 | 404.83 |
Net Cash Growth | -0.46% | 3.93% | -3.56% | 0.04% | 516.32% | 18.28% |
Net Cash Per Share Net Cash Per Share Growth | 19.90 | 20.12 | 19.26 | 19.91 | 25.14 | 4.31 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 123.54 | 130.16 | 154.08 | 151.11 | 375.21 | 104.4 |
Capital Expenditures CapEx Growth | -35.35 | -32.22 | -15.93 | -24.12 | -23.75 | -10.03 |
Free Cash Flow Free Cash Flow Growth | 88.19 | 97.94 | 138.16 | 126.98 | 351.46 | 94.38 |
Free Cash Flow Growth | -15.50% | -29.11% | 8.80% | -63.87% | 272.41% | -62.55% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 53.19% | 52.06% | 46.73% | 44.83% | 41.49% | 43.02% |
Operating Margin | 17.86% | 19.26% | 11.50% | 23.57% | 28.13% | 22.71% |
Pretax Margin | 19.00% | 22.54% | 20.88% | 29.76% | 30.74% | 24.73% |
Profit Margin | 15.97% | 19.46% | 18.42% | 26.49% | 26.87% | 21.99% |
FCF Margin | 7.33% | 8.45% | 16.38% | 11.31% | 24.83% | 14.24% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.471 | 0.471 | 0.286 | 0.510 | 1.020 |
Dividend Per Share Growth | 131.00% | 65.00% | -44.00% | -50.00% | - |
Dividend Yield | 1.06% | 0.78% | 0.64% | 0.84% | 0.95% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 28.76 | 33.76 | 36.05 | 26.21 | 36.95 | - |
Forward PE | 19.68 | 27.93 | 23.74 | 16.44 | 29.83 | - |
P/FCF Ratio | 62.50 | 77.77 | 40.54 | 61.36 | 39.98 | - |
PS Ratio | 4.58 | 6.57 | 6.64 | 6.94 | 9.93 | - |